Search
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 455 items.
In 2013, ISTODAX (romidepsin) was authorized under a Notice of Compliance with conditions (NOC/c) for the treatment of patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) who are not eligible for transplant and have received at least one…
AlertHealth professional risk communication | 2023-03-20
Health Canada is advising the public that Gilead Sciences Incorporated recalled two lots (032168 and 033357) of the cystic fibrosis drug Cayston (aztreonam) (DIN 02329840) on March 1, 2023, due to the potential of cracked glass vials in those lots, which…
AlertPublic advisory | 2023-03-18
Canada is experiencing a shortage of nitroglycerin 0.4 MG/ACT sprays due to supply issues with the raw materials used to make the sprays as well as an increase in demand.
Nitroglycerin sublingual spray is applied under the tongue and is used to treat…
AlertPublic advisory | 2023-03-17
Health Canada is warning parents and caregivers about two unauthorized children's syrups for thinning mucus, Robikids and Solmux, seized from Kamshoppe, which advertised the products on Facebook. Both products are labelled to contain carbocisteine, a…
AlertPublic advisory | 2023-03-16
Health Canada’s sampling and evaluation program has determined that the AIKSSOO brand baby gate does not meet Canada’s Expansion Gates and Expandable Enclosures Regulations. The top end cap of the extender piece can detach, releasing a small part that…
AlertConsumer product advisory | 2023-03-13
Health Canada is advising about unauthorized skin lightening products that may pose serious health risks. The products are labelled to contain or have been tested and found to contain dangerous ingredients. Health Canada updates the table when it finds…
AlertPublic advisory | 2023-03-06
Health Canada has become aware of edible cannabis products available for sale that contain a quantity of THC that exceeds the allowable limit of 10 mg of THC per package. Consumers of these items may accidentally consume higher than expected levels of…
AlertPublic advisory | 2023-03-03
Health Canada has determined that the use of these restraints in a motor vehicle could increase the risk of injury in the event of a collision.
These products do not display Transport Canada's National Safety Mark and therefore have not been…
AlertConsumer product advisory | 2023-03-01
Health Canada is warning consumers about unauthorized health products that it removed from sale from Kausch International Goods’ online Facebook store and its associated warehouse in Calgary, AB. The unauthorized products were labelled or previously…
AlertPublic advisory | 2023-03-01
Health Canada is warning consumers about an unauthorized health product, Kobayashi Eyebon Eye Wash, Cool format, which it seized from Oceanbuy, a store located in Markham ON, and removed from online sale. The unauthorized product was labelled in Japanese…
AlertPublic advisory | 2023-02-22
Health Canada seized unauthorized health products from two natural food stores in Sudbury, Ontario, because the products are labelled to contain prescription or controlled drugs, which may pose serious health risks.
The unauthorized products include…
AlertPublic advisory | 2023-02-20
Health Canada is warning consumers about an unauthorized health product, Solmux Carbocisteine Mucolytic, that it removed from sale from Palengke Pinoy, a retail store in Camrose, AB, and an online store on Facebook. This unauthorized product was…
AlertPublic advisory | 2023-02-17
Health Canada has determined that the epoxy kits do not meet the labelling requirements of the Consumer Chemicals and Containers Regulations, 2001 under the Canada Consumer Product Safety Act.
The lack of appropriate labelling information could result…
AlertConsumer product advisory | 2023-02-17
Currently available data from the NOVA study, based on a data cut-off date of October 1, 2020, shows that the median OS may be lower with ZEJULA compared to placebo for patients in the overall non-gBRCAmut cohort and the non-gBRCAmut / Homologous…
AlertHealth professional risk communication | 2023-02-16
Health Canada is advising about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as "…
AlertPublic advisory | 2023-02-10